EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY 4.0

From clinic to couch: a pilot study of home-use photobiomodulation for radiation-induced oral mucositis and dermatitis

Saeed Salman, Ragda Abdalla-Aslan, Ahmad Awawdi, Rana Tarabeih, Salem Billan

Supportive Care in Cancer · 2025

DOI: 10.1007/s00520-025-10037-3 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Supportive Care in Cancer, 2025. Verfasst von Saeed Salman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Fishman Oncology Center, Rambam Health Care Campus, Haifa, Israel. saeed.salman@technion.ac.il. Hauptthemen laut MEDLINE: Stomatitis, Low-Level Light Therapy, Head and Neck Neoplasms, Radiodermatitis. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: unconditional research grant from Erika B-Cure Laser Ltd, Technion - Israel Institute of Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Radiation-induced oral mucositis (OM) and dermatitis (RD) are common debilitating toxicities of radiotherapy (RT) for head and neck cancer (HNC) patients. While photobiomodulation (PBM) has shown promise in reducing severity of these adverse effects, in-clinic treatments pose logistic and financial challenges. This study assessed the feasibility and compliance of a home-use, self-applied near-infrared PBM device for the prevention and treatment of RT-induced OM and RD.

Methods

This prospective, single-arm trial enrolled 20 HNC patients scheduled for intensity-modulated RT (IMRT) with or without concurrent chemotherapy. Seventeen patients were analyzed following exclusions. Participants self-administered PBM at home twice daily for 9–11 weeks, from RT initiation to four weeks post-RT. The primary outcome was compliance (≥ 50% of expected treatments). Secondary outcomes included incidence of severe (grade 3–4) OM and RD.

Results

67% of the participants completed at least 50% of the prescribed PBM treatments. Overall, 60% of expected sessions were administered, surpassing the predefined compliance threshold. By week 3, 6% presented with severe OM and none with severe RD. At RT completion, 41% and 18% had severe OM and RD, respectively. Four weeks post-RT, no severe OM or RD were observed, with the majority presenting with no toxicity (grade 0). No device related adverse effects were reported, and patients reported high comfort and ease of use.

Conclusion

Self-administered, home-use PBM is a feasible and well-tolerated approach that shows promise as pre-emptive treatment for RT induced OM and RD. Large-scale, randomized, placebo-controlled trials are needed to confirm these findings and evaluate long-term benefits.

Trial registration

ClinicalTrials.gov Identifier: NCT05176834. Registration Date: December 13th, 2021.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StomatitisLow-Level Light TherapyHead and Neck NeoplasmsRadiodermatitisRadiation InjuriesHumansPilot ProjectsMaleFemaleProspective StudiesMiddle AgedAgedRadiotherapy, Intensity-ModulatedAdultFeasibility StudiesPatient ComplianceSelf Care

Stichwörter der Autor:innen

Head and neck neoplasmsIntensity-modulated radiotherapyLow-level laser therapyOral mucositisPhotobiomodulation therapyRadiation-induced dermatitis

Autor:innen und Institutionen

  • Fishman Oncology Center, Rambam Health Care Campus, Haifa, Israel. saeed.salman@technion.ac.il.
  • Ruth & Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. saeed.salman@technion.ac.il.
  • Oral and Maxillofacial Surgery Department, Rambam Health Care Campus, Haifa, Israel.
  • Ruth & Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Fishman Oncology Center, Rambam Health Care Campus, Haifa, Israel.

Förderung

  • unconditional research grant from Erika B-Cure Laser Ltd
  • Technion - Israel Institute of Technology

Zitieren

APA

Salman, S., Abdalla-Aslan, R., Awawdi, A., Tarabeih, R., & Billan, S. (2025). From clinic to couch: a pilot study of home-use photobiomodulation for radiation-induced oral mucositis and dermatitis. Supportive Care in Cancer. https://doi.org/10.1007/s00520-025-10037-3

Vancouver

Salman S, Abdalla-Aslan R, Awawdi A, Tarabeih R, Billan S. From clinic to couch: a pilot study of home-use photobiomodulation for radiation-induced oral mucositis and dermatitis. Supportive Care in Cancer. 2025. doi:10.1007/s00520-025-10037-3

BibTeX
@article{Salman2025,
  author = {Salman, Saeed and Abdalla-Aslan, Ragda and Awawdi, Ahmad and Tarabeih, Rana and Billan, Salem},
  title = {From clinic to couch: a pilot study of home-use photobiomodulation for radiation-induced oral mucositis and dermatitis},
  journal = {Supportive Care in Cancer},
  year = {2025},
  doi = {10.1007/s00520-025-10037-3}
}
Kostenlos starten →